The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| PRFX | -80.65% | -99.95% | -77.83% | -100% |
| S&P | +13.95% | +78.35% | +12.25% | +97% |
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
No news articles found for Prf Technologies.
| Q2 2024 | YOY Change | |
|---|---|---|
| Revenue | $0.00K | 0.0% |
| Gross Profit | -$4.00K | 0.0% |
| Market Cap | $4.44M | 0.0% |
| Net Income | -$7,312.00K | 0.0% |
| EBITDA | -$7,341.00K | 0.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2024 | YOY Change | |
|---|---|---|
| Net Cash | $2.79M | 0.0% |
| Inventory | 0 | 0.0% |
| Q2 2024 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.00K | 0.0% |
| Short Term Debt | $57.00K | 0.0% |
| Q2 2024 | YOY Change | |
|---|---|---|
| Return On Assets | -309.43% | 0.0% |
| Return On Invested Capital | -50.01% | 0.0% |
| Q2 2024 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$4,883.06K | 0.0% |
| Operating Free Cash Flow | -$4,878.16K | 0.0% |
| Metric | Q1 2024 | Q2 2024 | YoY Change |
|---|---|---|---|
| Price to Book | 2.17 | 2.40 | - |
| Price to Tangible Book Value | 52.14 | 57.67 | - |
| Enterprise Value to EBITDA | 0.10 | 0.15 | - |
| Return on Equity | -233.5% | -716.7% | - |
| Total Debt | $72.00K | $59.00K | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
